The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of lansoprazole microgranules
oral suspension, once daily (QD), in infants with gastroesophageal reflux symptoms during a
4-week treatment period.